SAN DIEGO--(BUSINESS WIRE)--Pathway Genomics, a global precision medical diagnostics company with mobile health applications designed to empower physicians and their patients to take control of their health and wellness, announced today the launch of a limited time pricing of $99 for the Pathway Fit® genetic test.
According to the World Health Organization (WHO), more than one billion adults and 42 million children are overweight or obese, with nearly three million people dying each year as the result of chronic health conditions such as diabetes and cardiovascular disease caused by their weight. Obesity is a significant public health concern reaching epidemic proportion, especially in the United States.
“Genetic testing is taking medical nutrition therapy to a new level where we can individualize lifestyle interventions to optimize outcomes based on a better understanding of what works and what does not, advancing precision medicine in this field,” said Dr. Osama Hamdy, MD, PhD Medical Director of the Obesity Clinical Program at Joslin Diabetes Center and Assistant Professor of Medicine at Harvard Medical School.
Pathway Fit® analyzes over 75 genetic markers known to impact metabolism, exercise, and energy consumption use within the human body. The test is a personalized nutrigenomic profile that provides individualized information to physicians and their patients in order to help them understand how genetics and lifestyle may impact their diet, nutrition, and exercise.
“Pathway Genomics is dedicated to delivering high-quality personalized genetic testing results ordered by a physician that allows patients to take control of their own health. Pathway Fit® was developed with the global obesity issue in mind as a way to help individuals combat the disease,” said Ardy Arianpour, Pathway Genomics’ Chief Commercial Officer. “We believe in giving patients the tools to optimize their mental and physical performance in order to achieve a healthier lifestyle; with this $99 promotion on Pathway Fit®, we are giving patients the opportunity to reach their performance goals.”
Studies have shown that people on a genetically appropriate diet can lose significantly more weight, compared to those on a diet not based on genetics. By providing patients with this valuable information about which diet is most appropriate for them based on their individualized genetic profile, Pathway Fit® aims to assist patients in meeting both their weight loss and overall health goals.
For a limited time, Pathway Genomics will be offering Pathway Fit® for $99 when it is requested through our online mobile app using a physician designated by Pathway. Pathway Genomics mobile app is now available on Android and iOS.
To learn more about Pathway Fit®, visit www.pathway.com/pathway-fit-promo.
About Pathway Genomics Corporation
Since its founding in 2008, Pathway Genomics has rapidly become a leader in the commercial healthcare industry. Pathway Genomics’ success lies in its commitment to deliver innovative healthcare solutions. The company’s program with IBM Watson is the first of its kind. The program is a smartphone app that merges artificial intelligence and deep learning with personal genetic information. The app provides users with personalized health and wellness information based on the individual’s health history.
Based in San Diego, the company’s CLIA and CAP accredited clinical laboratory provides physicians and their patients in more than 40 different countries with actionable and accurate precision healthcare information to improve, or maintain, health and wellness. Pathway Genomics’ testing services cover a variety of conditions including cancer risk, cardiac health, inherited diseases, nutrition and exercise response, as well as drug response for specific medications including those used in pain management and mental health. For more about Pathway Genomics, visit https://www.pathway.com or follow us on Twitter, LinkedIn and Facebook.